Trial intelligence / Profile preview

Histamine Blockade in Resistance Training

NCT06152497Recruiting

Sponsor
Ghent University
Start
Sep 2023
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Placebo with Telfast (2 arms). Primary endpoints: Muscle volume at 10 weeks, Maximal dynamic strength of leg press, bench press, bicep curl and leg curl at 10 weeks and 3 more. Started Sep 2023; status: recruiting.

02

Drugs

antihistamine (TDDS/ODF)

Beyond the preview

Go deeper on NCT06152497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06152497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call